ISRG vs SYK
ISRG and SYK side by side — valuation & fundamentals (public data).
Key statistics
| Metric | ISRGIntuitive Surgical, Inc. | SYKSTRYKER CORP |
|---|---|---|
| Market cap | $149.80B | $110.94B |
| P/E (TTM) | 52.3 | 31.0 |
| P/B | 9.37 | 9.46 |
| P/S | 14.9x | 4.4x |
| Dividend yield | — | 1.16% |
| Revenue | $11.58B(TTM) | $26.30B(TTM) |
| Revenue growth (YoY) | 20.5% | 11.2% |
| Net income | $2.96B(TTM) | $3.62B(TTM) |
| Earnings growth (YoY) | 23.0% | 8.5% |
| EPS, diluted | $8.27(TTM) | $9.39(TTM) |
| EBIT margin | 29.3% | 19.5% |
| ROE | 17.9% | 27.7% |
| ROIC | — | 15.0% |
| Piotroski F | — | 9/9 |
| 1y total return | -18.5% | -20.2% |
Figures from SEC filings · for reference only · not investment advice
Growth of $10,000: ISRG vs SYK
| Metric | ISRG | SYK |
|---|---|---|
| End value | $59.1K | $27.5K |
| Total return | +491.1% | +174.6% |
| CAGR | +18.8% | +10.3% |
| Volatility | 32.8% | 26.9% |
| Sharpe | 0.56 | 0.34 |
| Sortino | 0.81 | 0.49 |
| Max drawdown | -49.9% | -43.8% |
Based on 2600 common trading days, 2016-06-29 → 2026-10-30 · risk-free 4.16% (current short-Treasury, held constant)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)